Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA.
Am J Clin Pathol. 2022 Nov 3;158(5):639-645. doi: 10.1093/ajcp/aqac107.
We aimed to better understand the histologic changes in vaginectomy specimens in transgender and gender-diverse (TGD) individuals after prolonged androgen administration.
After obtaining institutional review board approval, we reviewed clinical records for all TGD individuals who underwent vaginal tissue resection at our institution between January 2002 and July 2020.
Ten transgender males who underwent vaginectomy for gender affirmation were identified. All patients had been assigned female gender at birth, and the median age at surgery was 41 years (range, 22-74 years). All 10 patients had received androgen for 2 to 10 years preoperatively. The corresponding pathology specimens were examined grossly and microscopically, including with immunohistochemical stains for NKX3.1, prostate-specific antigen (PSA), p501s, and androgen receptor (AR). No gross lesions were identified. Microscopically, prostate-like glands (8/10), urothelial metaplasia (4/10), and vaginal atrophy (8/10) were identified. Seven cases with prostate-like glands showed positive staining with PSA, NKX3.1, p501s, and AR in both squamous and glandular components.
Recognition of these androgen-related changes enables pathologist to avoid the overdiagnosis of dysplasia. Long-term follow-up is needed to thoroughly understand any potential future implications of these androgen-related changes.
我们旨在更好地了解长期雄激素治疗后 transgender 和性别多样化(TGD)个体阴道切除术标本的组织学变化。
在获得机构审查委员会批准后,我们回顾了 2002 年 1 月至 2020 年 7 月期间在我们机构接受阴道组织切除的所有 TGD 个体的临床记录。
确定了 10 名接受阴道成形术以进行性别肯定的跨性别男性。所有患者出生时均被分配为女性,手术时的中位年龄为 41 岁(范围 22-74 岁)。所有 10 例患者术前均接受雄激素治疗 2 至 10 年。相应的病理标本进行了大体和显微镜检查,包括 NKX3.1、前列腺特异性抗原(PSA)、p501s 和雄激素受体(AR)的免疫组织化学染色。未发现明显病变。显微镜下,发现 8/10 例有前列腺样腺体,4/10 例有尿路上皮化生,8/10 例有阴道萎缩。7 例有前列腺样腺体的病例显示 PSA、NKX3.1、p501s 和 AR 在鳞状和腺体成分中均呈阳性染色。
认识到这些与雄激素相关的变化使病理学家能够避免过度诊断发育不良。需要进行长期随访,以彻底了解这些与雄激素相关的变化可能带来的任何潜在影响。